DZ743A1 - Nouveaux dérivés de la furo-(3,4-c)-pyridine substitues en position 6, ainsi que leur procédé de préparation. - Google Patents

Nouveaux dérivés de la furo-(3,4-c)-pyridine substitues en position 6, ainsi que leur procédé de préparation.

Info

Publication number
DZ743A1
DZ743A1 DZ850024A DZ850024A DZ743A1 DZ 743 A1 DZ743 A1 DZ 743A1 DZ 850024 A DZ850024 A DZ 850024A DZ 850024 A DZ850024 A DZ 850024A DZ 743 A1 DZ743 A1 DZ 743A1
Authority
DZ
Algeria
Prior art keywords
well
preparation process
pyridine derivatives
derivatives substituted
furo
Prior art date
Application number
DZ850024A
Other languages
English (en)
French (fr)
Inventor
Andre Esanu
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Application granted granted Critical
Publication of DZ743A1 publication Critical patent/DZ743A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
DZ850024A 1984-02-02 1985-01-26 Nouveaux dérivés de la furo-(3,4-c)-pyridine substitues en position 6, ainsi que leur procédé de préparation. DZ743A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848402740A GB8402740D0 (en) 1984-02-02 1984-02-02 Furo-(3 4-c)-pyridine derivatives

Publications (1)

Publication Number Publication Date
DZ743A1 true DZ743A1 (fr) 2004-09-13

Family

ID=10555953

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ850024A DZ743A1 (fr) 1984-02-02 1985-01-26 Nouveaux dérivés de la furo-(3,4-c)-pyridine substitues en position 6, ainsi que leur procédé de préparation.

Country Status (24)

Country Link
US (1) US4581362A (es)
JP (1) JPS60181088A (es)
AT (1) AT391700B (es)
BE (1) BE901545A (es)
CA (1) CA1300148C (es)
CH (1) CH663023A5 (es)
DE (1) DE3503435A1 (es)
DK (1) DK158951C (es)
DZ (1) DZ743A1 (es)
ES (1) ES8607308A1 (es)
FI (1) FI82051C (es)
FR (2) FR2559062B1 (es)
GB (1) GB8402740D0 (es)
HK (1) HK92587A (es)
IE (1) IE58229B1 (es)
IT (1) IT1200587B (es)
LU (1) LU85744A1 (es)
MA (1) MA20342A1 (es)
NL (1) NL8500241A (es)
NO (1) NO160369C (es)
OA (1) OA07947A (es)
PT (1) PT79913B (es)
SE (2) SE460903B (es)
ZA (1) ZA85508B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
JPH054664A (ja) * 1991-06-21 1993-01-14 Yoozuri:Kk 運搬等用の包装体及び包装方法
PE20221914A1 (es) 2011-12-28 2022-12-23 Global Blood Therapeutics Inc Compuestos de benzaldehido sustituidos y metodos para su uso en incrementar la oxigenacion del tejido
EP2797597B1 (en) 2011-12-28 2020-02-26 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
CN112500338A (zh) 2013-03-15 2021-03-16 全球血液疗法股份有限公司 化合物及其用于调节血红蛋白的用途
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
AU2014237330A1 (en) 2013-03-15 2015-09-17 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
KR101971385B1 (ko) 2013-03-15 2019-04-22 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
AU2015214182B2 (en) 2014-02-07 2020-04-30 Global Blood Therapeutics, Inc. Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
MA43373A (fr) 2015-12-04 2018-10-10 Global Blood Therapeutics Inc Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde
TWI663160B (zh) 2016-05-12 2019-06-21 全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
WO2020072377A1 (en) 2018-10-01 2020-04-09 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use
IN156817B (es) * 1981-02-10 1985-11-09 Scras
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives

Also Published As

Publication number Publication date
NL8500241A (nl) 1985-09-02
OA07947A (fr) 1987-01-31
JPS60181088A (ja) 1985-09-14
ES8607308A1 (es) 1986-05-16
FI850275L (fi) 1985-08-03
CA1300148C (en) 1992-05-05
FI850275A0 (fi) 1985-01-22
FI82051B (fi) 1990-09-28
NO160369C (no) 1989-04-12
DK158951C (da) 1990-12-31
SE460903B (sv) 1989-12-04
FR2559152A1 (fr) 1985-08-09
PT79913B (en) 1986-11-10
AT391700B (de) 1990-11-12
ZA85508B (en) 1985-11-27
DK158951B (da) 1990-08-06
IE58229B1 (en) 1993-08-11
FR2559062B1 (fr) 1987-05-22
DK45585D0 (da) 1985-02-01
FR2559152B1 (fr) 1987-05-22
CH663023A5 (fr) 1987-11-13
FR2559062A1 (fr) 1985-08-09
DE3503435A1 (de) 1985-08-08
SE8500460L (sv) 1985-08-03
JPH0240069B2 (es) 1990-09-10
IT1200587B (it) 1989-01-27
BE901545A (fr) 1985-07-22
IT8519327A0 (it) 1985-02-01
PT79913A (en) 1985-03-01
NO160369B (no) 1989-01-02
FI82051C (fi) 1991-01-10
ES540080A0 (es) 1986-05-16
SE8500460D0 (sv) 1985-02-01
DK45585A (da) 1985-08-03
GB8402740D0 (en) 1984-03-07
MA20342A1 (fr) 1985-10-01
US4581362A (en) 1986-04-08
DE3503435C2 (es) 1991-11-07
IE850241L (en) 1985-08-02
HK92587A (en) 1987-12-11
NO850399L (no) 1985-08-05
ATA27585A (de) 1990-05-15
LU85744A1 (fr) 1985-07-24

Similar Documents

Publication Publication Date Title
DZ743A1 (fr) Nouveaux dérivés de la furo-(3,4-c)-pyridine substitues en position 6, ainsi que leur procédé de préparation.
DZ376A1 (fr) Nouveaux dérivés de la furo (3,4-c)-pyridine et leur préparation.
DZ701A1 (fr) Nouveaux dérivés de la vinyl-6, furo-(3,4-c)-pyridine ainsi que leur procédé de préparation.
DZ702A1 (fr) Nouveaux dérivés de la carboxymethoxy-7 furo-(3,4-c)-pyridine ainsi que leur procédé de préparation.
OA08481A (fr) Dérivés d'indolizine, leur procédé de préparation ainsi que les compositions les contenant.
MA19716A1 (fr) Procede de preparation de nouveaux derives 3- ceto a 4,9 19- norsteroides .
RO91871A (ro) Procedeu pentru prepararea unor derivati de 1,4-dihidro-4-oxonaftiridina
OA07699A (fr) Dérivés de la furo-(3,4-c)-pyridine leur préparation et compositions thérapeutiques contenant ces dérivés.
OA06811A (fr) Procédé de préparation de nouveaux dérivés de pyridoxine.
OA05575A (fr) Nouveaux dérivés d'indolizine, leur procédé de préparation ainsi que les compositions les contenant.
OA06951A (fr) Dérivés de la thiéno-pyridinone, leur procédé de préparation et leur application thérapeutique.
OA05403A (fr) Nouveaux dérivés de la thiazolo [3,4-b] isoquinoléine et leur procédé de préparation.
DZ1499A1 (fr) Méthode de préparation de dérivés de furo (3,4-c)pyridine sous forme non-racémique.
DZ687A1 (fr) Dérivés de la chlori-4-furo-(3,4-c)-pyridine et leur procédé de préparation.
DZ850A1 (fr) Nouveaux dérivés de la phénéthylaminoalcoyle-6 furo-(3,4-c)-pyridine et leur procédé de préparation.
FR2566779B2 (fr) Nouveaux derives steroides substitues en 11b, leur procede de preparation et leur application comme medicaments
IT8020700A0 (it) Processo per la preparazione di derivati di 5,11-di-idro-6h-pirido(2,3-b) (1,4)-benzodiazepin-6-one, derivati finali ed intermedi di sintesi in tal modo ottenuti.
OA08088A (fr) Nouveau procédé de préparation des dérivés de la furo-(3,4-C)-pyridine substitués en position 6.
DZ851A1 (fr) Nouveaux dérivés de la pyridine et leur procédé depréparation.
DZ773A1 (fr) Nouveaux dérivés du pyrane ainsi que leur procédé de préparation.
ES546136A0 (es) Proceso para producir derivados de 1,4-dihidro-piridina-3,5,dicarboxilato.
DZ779A1 (fr) Nouveaux dérivés de la quinoléine ainse que leur procédé de préparation.
OA08076A (fr) Acide dihdro-5,6-4H-cyclopenta[b] thiophènecarboxyliques-6, procédés de préparation.
MA20517A1 (fr) Nouveaux derives de l'aminomethyle-6 furo-(3,4-c)-pyridine ainsi que leur procede de preparation
OA05555A (fr) Dérivés de 1,3-dihydro-l'-diméthylphoephinylalkyl-3-phénylspiro [isobenzofuranne-cycloazalcanes], leur procédé de préparation et leur application.